# Japanese Phase I of GSK1605786

> **NCT01611805** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 30 (actual)

## Conditions studied

- Crohn's Disease

## Interventions

- **DRUG:** GSK1605786
- **DRUG:** GSK1605786 Placebo

## Key facts

- **NCT ID:** NCT01611805
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-07-22
- **Primary completion:** 2010-10-06
- **Final completion:** 2010-10-06
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2017-06-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01611805

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01611805, "Japanese Phase I of GSK1605786". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01611805. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*